Effectiveness of Regular Reporting of Spirometric Results on Smoking Quit Rate. (ESPIROTAB)
Effectiveness of Regular Reporting of Spirometric Results Combined With a Smoking Cessation Advice by a Primary Care Physician on Smoking Quit Rate in Adult Smokers: a Randomized Controlled Trial.
Sponsor: Catalan Institute of Health
A NA clinical study on COPD and Smoking Cessation, this trial is ongoing. The trial is conducted by Catalan Institute of Health and has accumulated 6 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Mar 2023 — Jul 2024 [monthly]
Unknown Status NA
-
Jan 2021 — Mar 2023 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Jan 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Catalan Institute of Health
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
- Research Support Unit Metropolitana Nord, Barcelona, Spain
For direct contact, visit the study record on ClinicalTrials.gov .